Zhiliang Cheng, Ph.D.
About Zhiliang Cheng, Ph.D.
Education and Expertise
Zhiliang Cheng, Ph.D., earned his bachelor's degree in Biological Sciences from the University of Science and Technology of China. He pursued advanced studies and completed his Ph.D. in Biochemistry and Molecular Pharmacology at the University of Massachusetts Medical School. Following this, he underwent postdoctoral training at the University of California, Berkeley, where he served as an HHMI research specialist. Cheng's educational background has equipped him with deep expertise in biochemistry and molecular pharmacology.
Professional Background
Zhiliang Cheng, Ph.D., has a robust professional background in the biotechnology and pharmaceutical industries. He has held significant leadership roles, including serving as the Vice President of Research Science at Inozyme Pharma. Cheng has extensive experience leading research and development (R&D) teams at both Regeneron and Alexion. His career is marked by contributions to the development of therapies for cardiovascular, metabolic, and musculoskeletal diseases.
Research Leadership at Inozyme Pharma
At Inozyme Pharma, Zhiliang Cheng, Ph.D., served as the Vice President of Research Science. In this role, he led efforts to advance the company's R&D initiatives. Under his leadership, the research teams focused on creating innovative solutions for rare diseases. Cheng's role included overseeing the development of enzyme replacement therapy (ERT) and mRNA therapeutics, contributing to significant advancements in these fields.
Experience in Cardiovascular, Metabolic, and Musculoskeletal Research
Zhiliang Cheng, Ph.D., has led research teams that concentrated on tackling complex health issues related to cardiovascular, metabolic, and musculoskeletal diseases. His work has encompassed both the strategic direction and hands-on development of innovative treatments. Cheng's contributions have been integral to advancing therapeutic options, particularly in the realm of rare diseases, demonstrating his leadership and expertise in these critical areas of medical research.